These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37477102)

  • 1. Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis.
    Lee D; Kim YN; Cho SH; Yoon HS; Kim YT; Kim S; Kim SW
    J Gynecol Oncol; 2023 Nov; 34(6):e79. PubMed ID: 37477102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
    Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
    Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does sentinel node mapping impact morbidity and quality of life in endometrial cancer?
    Goncalves BT; Dos Reis R; Ribeiro R; Moretti-Marques R; Schamme FK; Oliveira GS; Tsunoda AT; Alvarenga-Bezerra V; Lopes A; Pastore CBP; Kumagai LY; Faloppa CC; Mantoan H; Badiglian-Filho L; De Brot L; Andrade CEMC; Baiocchi G
    Int J Gynecol Cancer; 2023 Oct; 33(10):1548-1556. PubMed ID: 37699707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel Lymph Node Sampling as an Alternative to Lymphadenectomy in Patients With Endometrial Cancer and Obesity.
    Matanes E; Eisenberg N; Amajoud Z; Gupta V; Yasmeen A; Ismail S; Racovitan F; Raban O; Lau S; Salvador S; Gotlieb WH; Kogan L
    J Obstet Gynaecol Can; 2021 Oct; 43(10):1136-1144.e1. PubMed ID: 33984524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
    Schlappe BA; Weaver AL; McGree ME; Ducie J; Zahl Eriksson AG; Dowdy SC; Cliby WA; Glaser GE; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2020 Jan; 156(1):62-69. PubMed ID: 31776037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel Lymph Node Mapping vs Systematic Lymphadenectomy for Endometrial Cancer: Surgical Morbidity and Lymphatic Complications.
    Accorsi GS; Paiva LL; Schmidt R; Vieira M; Reis R; Andrade C
    J Minim Invasive Gynecol; 2020; 27(4):938-945.e2. PubMed ID: 31421249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of sentinel lymph node mapping on survival in patients with high-risk endometrial cancer in the early stage: A matched cohort study.
    Jaafar E; Gaultier V; Wohrer H; Estevez JP; Gonthier C; Koskas M
    Int J Gynaecol Obstet; 2024 May; 165(2):677-684. PubMed ID: 38226675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes.
    Matanes E; Eisenberg N; Lau S; Salvador S; Ferenczy A; Pelmus M; Gotlieb WH; Kogan L
    Gynecol Oncol; 2021 Aug; 162(2):256-261. PubMed ID: 34119364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of comorbidities and extent of lymphadenectomy on quality of life in endometrial cancer patients treated with minimally invasive surgery in the era of sentinel lymph nodes.
    Dinoi G; Multinu F; Yost K; AlHilli M; Larish A; Langstraat C; Kumar A; Weaver AL; McGree M; Cheville A; Dowdy S; Mariani A; Glaser G
    Int J Gynecol Cancer; 2023 Aug; 33(8):1227-1236. PubMed ID: 37419517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The added value of sentinel node mapping in endometrial cancer.
    Kogan L; Matanes E; Wissing M; Mitric C; How J; Amajoud Z; Abitbol J; Yasmeen A; López-Ozuna V; Eisenberg N; Lau S; Salvador S; Gotlieb WH
    Gynecol Oncol; 2020 Jul; 158(1):84-91. PubMed ID: 32349874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy.
    Leitao MM; Zhou QC; Gomez-Hidalgo NR; Iasonos A; Baser R; Mezzancello M; Chang K; Ward J; Chi DS; Long Roche K; Sonoda Y; Brown CL; Mueller JJ; Gardner GJ; Jewell EL; Broach V; Zivanovic O; Dowdy SC; Mariani A; Abu-Rustum NR
    Gynecol Oncol; 2020 Jan; 156(1):147-153. PubMed ID: 31780238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy.
    Buda A; Gasparri ML; Puppo A; Mereu L; De Ponti E; Di Martino G; Novelli A; Tateo S; Muller M; Landoni F; Papadia A
    Gynecol Oncol; 2018 Aug; 150(2):261-266. PubMed ID: 29887483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer.
    Matsuo K; Klar M; Khetan VU; Violette CJ; Youssefzadeh AC; Yessaian AA; Roman LD
    Eur J Obstet Gynecol Reprod Biol; 2022 Aug; 275():91-96. PubMed ID: 35763967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancer.
    Makroum AA; Lee YJ; Lee JY; Nam EJ; Kim S; Kim SW; Kim YT
    J Obstet Gynaecol Res; 2023 Aug; 49(8):2118-2125. PubMed ID: 37286510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
    Ducie JA; Eriksson AGZ; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Soslow RA; Keeney GL; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2017 Dec; 147(3):541-548. PubMed ID: 28965698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical and oncological outcomes of sentinel lymph node sampling in elderly patients with intermediate to high-risk endometrial carcinoma.
    Matanes E; Eisenberg N; Mitric C; Yasmeen A; Ismail S; Raban O; Cantor T; Knigin D; Lau S; Salvador S; Gotlieb W; Kogan L
    Int J Gynecol Cancer; 2022 Jul; 32(7):875-881. PubMed ID: 35680137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
    Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
    Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes.
    Casarin J; Multinu F; Tortorella L; Cappuccio S; Weaver AL; Ghezzi F; Cilby W; Kumar A; Langstraat C; Glaser G; Mariani A
    Int J Gynecol Cancer; 2020 Jan; 30(1):41-47. PubMed ID: 31780567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.